EDMONTON, Alberta–(BUSINESS WIRE)–BioAlberta has published its 2023 State of the Industry (SOI) report. This year’s…
DANIA BEACH, Fla.–(BUSINESS WIRE)–IntelePeer, a leading provider of AI-powered communications automation solutions, today announced the…
CONSOLIDATED FIGURES AS AT JUNE 30in € million 2023 2022 restated5 2023/2022 change …
GUILFORD, Conn., Sept. 28, 2023 (GLOBE NEWSWIRE) — AI Therapeutics, Inc., a clinical-stage biopharmaceutical company…
Pombiliti + Opfolda Logo Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) Approved in ERT-Experienced Adults First…
Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers…
DALLAS, Sept. 28, 2023 (GLOBE NEWSWIRE) — Spectral MD, Inc. (“SMD”), a subsidiary of Spectral…
SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company…
Thanks Stakeholders who Advocated for Patients CANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — Organogenesis…
Nord Security doubled its valuation in an investment round led by a global growth investor…
BREDARYD, SWEDEN, Sept 28, 2023 – (ACN Newswire) – In a dedicated effort to enhance…
Toronto, Ontario–(ACN Newswire – September 28, 2023) – Appia Rare Earths & Uranium Corp. (CSE: API)…
Recognized for its Innovative AI Solutions for Insurance Underwriting and Claims Management BOSTON–(BUSINESS WIRE)–#AIinInsurance—Gradient AI,…
Contract will support continued development of Sarcos artificial intelligence and machine learning framework to advance…
Providing investors a differentiated income strategy which couples high income potential with long term growth…
Students enter by submitting a video about the future of AI in real estate LOS…
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure SCORED was one of…
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure SCORED was one of…